AIM Self-Assessment: Volume Three

Price: $199 for College Members, $299 for non-members, $25 for Member Fellows-in-Training

College membership is free for Fellows-in-Training

You can earn up to 22 AMA PRA Category 1 Credit(s)™. 

This third Allergy & Immunology Medicine self-assessment module is designed to help allergy/immunology providers obtain new knowledge, as well as reaffirm existing knowledge. It also helps allergists/immunologists evaluate and maintain their clinical competence. The module consists of 109 case-based, multiple-choice questions. Comprehensive discussions provide evidence-based explanations regarding all answer options, along with supporting references from the current literature.

There are 4 modes within this module: Pretest, Learn, Posttest and Comparison.

Pretest: This initial self-audit allows for one to identify their gaps in knowledge related to established knowledge in allergy and immunology. Answer each question once and receive a Pretest Score at the end.

Learn: This study mode allows one to answer questions, review evidence-based discussions, and link to PubMed abstracts of the references. Answer each question until the correct answer is chosen, then read the discussion and view the references. If you answer incorrectly, you will be given a brief statement on why that answer choice is incorrect. The comprehensive discussion includes rationale for all answer options, whether they are correct or incorrect.

Posttest: This final audit allows one to measure the amount of learning that has occurred. Answer each question once and receive a Posttest Score at the end. One has 3 attempts to achieve a passing score of 80% or better.

Comparison: This final mode provides a comparison chart showing one’s pretest vs posttest scores, and a peer-to-peer comparison that shows how one compares to their colleagues answering the same questions.

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 22 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABAI designates this program for 22 ABAI MOC Part II (Self-Assessment) credits.

Commercial Support
There is no commercial support for this activity.

Target Audience

Practicing Allergy/Immunology Providers and Fellows in Training.

Learning Objectives

At the conclusion of this course, participants should be able to:

  • Identify, evaluate and manage current concerns and issues related to the pathophysiology, diagnosis and treatment of allergic and immunologic diseases
  • Demonstrate a mastery of key concepts in allergy and immunology
  • Summarize the practical application of key concepts in allergy and immunology in the management of clinical problems
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months. The ACCME defines an “ineligible company” as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. Examples of such organizations include:

•    Advertising, marketing, or communication firms whose clients are ineligible companies
•    Bio-medical startups that have begun a governmental regulatory approval process
•    Compounding pharmacies that manufacture proprietary compounds
•    Device manufacturers or distributors
•    Diagnostic labs that sell proprietary products
•    Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
•    Manufacturers of health-related wearable products
•    Pharmaceutical companies or distributors
•    Pharmacy benefit managers
•    Reagent manufacturers or sellers

The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.

Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All relevant financial relationships have been mitigated.

Course summary
Available credit: 
  • 22.00 AMA PRA Category 1 Credit™
  • 22.00 Attendance
  • 22.00 CBRN
  • 22.00 MOC
Course opens: 
01/21/2026
Course expires: 
01/21/2029
Cost:
$299.00
Rating: 
0

Authors /Editors

Gerald Lee, MD Co- Editor-in Chief
Associate Professor of Pediatrics and Medicine, Emory University School of Medicine
Atlanta, GA
Disclosures: Nothing to disclose

Christopher Foster, MD Co-Editor-Chief
Naval Medical Center San Diego/NTC Allergy & Immunology
San Diego, CA
Disclosures: Nothing to disclose

Edsel M. Abud, MD, PhD
Division of Allergy, Asthma, and Immunology, Scripps Clinic
San Diego, CA
Disclosures: Consultant/Advisor/Stock: Neucyte, Inc., Stem Pharm, Inc.
Advisor/Consultant: AstraZenenca
Royalties or Patent Beneficiary: UC Regents

Juanita Coke, MD
Assistant Professor, Division of Allergy and Immunology, LSU- Health
Shreveport, LA
Disclosures: Nothing to disclose

Tracy B. Fausnight MD 
Division Chief, Pediatric Allergy and Immunology, Penn State Health Children's Hospital 
Professor of Pediatrics and Medicine, Penn State College of Medicine
Disclosures: Nothing to disclose

Jessica W. Hui-Beckman, MD
Assistant Professor of Pediatrics, Allergy and Immunology, National Jewish Health
Denver, CO
Disclosures: Nothing to disclose

Min Jung Lee, MD
Hoag Medical Group
Irvine, CA
Disclosures: Nothing to disclose

Jonathan Olsen, DO
Clinical Assistant Professor, Allergy & Immunology, University of Utah
Salt Lake City, UT
Disclosures: Advisor: GlaxoSmithKline

Dylan Timberlake, MD
Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine
Cleveland, OH
Disclosures: Nothing to disclose

Gregory R. Toci, DO
Private Practice, Advocare Allergy & Asthma
Marlton, NJ
Disclosures: Speaker: AstraZeneca, Kedrion, Regeneron, Sanofi

Stephanie Ward MD, MEd
Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children’s Hospital
Medical Center, University of Cincinnati School of Medicine
Cincinnati, OH
Disclosures: Nothing to disclose

Katelyn Wong, MD
Yale School of Medicine
New Haven, CT
Disclosures: Nothing to disclose

Available Credit

  • 22.00 AMA PRA Category 1 Credit™
  • 22.00 Attendance
  • 22.00 CBRN
  • 22.00 MOC

Price

Cost:
$299.00
Please login or create an account to take this course.